Skip to main content
Signal8

SANDS ARTHUR T

SEC insider (Form 3/4/5 filer). CIK 0001134106. President, CEO at Nurix Therapeutics, Inc. (NRIX). 2 reported Form 4/5 transactions since Sep 2024; latest on Feb 10, 2026. Located in BRISBANE, CA.

Companies SANDS ARTHUR T has filed insider reports for

  • Nurix Therapeutics, Inc. (NRIX): Director, Officer, President, CEO
SANDS ARTHUR T profile photo

SANDS ARTHUR T

CIK: 0001134106

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Nurix Therapeutics, Inc. logo
NRIX

Nurix Therapeutics, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Nurix Therapeutics, Inc. logo
    NRIX

    Nurix Therapeutics, Inc.

    Feb 10, 2026
    Award

    Employee Stock Option (right to buy)

    Direct
    562.5K shares-
  • Nurix Therapeutics, Inc. logo
    NRIX

    Nurix Therapeutics, Inc.

    Feb 11, 2025
    Award

    Employee Stock Option (right to buy)

    Direct
    450K shares-

1-2 of 2